世界の代謝型グルタミン酸受容体3市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV07616)
◆英語タイトル:Global Metabotropic Glutamate Receptor 3 Market Insights and Forecast to 2026
◆商品コード:QYR20NV07616
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは代謝型グルタミン酸受容体3の世界市場について調査・分析した資料です。種類別(LY-3020371、VU-0092273、DT-010991、その他)の市場規模、用途別(自閉症、慢性疼痛、神経膠腫、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別代謝型グルタミン酸受容体3の競争状況、市場シェア
・世界の代謝型グルタミン酸受容体3市場:種類別市場規模 2015年-2020年(LY-3020371、VU-0092273、DT-010991、その他)
・世界の代謝型グルタミン酸受容体3市場:種類別市場規模予測 2021年-2026年(LY-3020371、VU-0092273、DT-010991、その他)
・世界の代謝型グルタミン酸受容体3市場:用途別市場規模 2015年-2020年(自閉症、慢性疼痛、神経膠腫、その他)
・世界の代謝型グルタミン酸受容体3市場:用途別市場規模予測 2021年-2026年(自閉症、慢性疼痛、神経膠腫、その他)
・北米の代謝型グルタミン酸受容体3市場分析:米国、カナダ
・ヨーロッパの代謝型グルタミン酸受容体3市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの代謝型グルタミン酸受容体3市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の代謝型グルタミン酸受容体3市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの代謝型グルタミン酸受容体3市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Addex Therapeutics Ltd、Aevi Genomic Medicine Inc、Denovo Biopharma LLC、Domain Therapeutics SA、Eli Lilly and Company、Prexton Therapeutics SA
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Metabotropic Glutamate Receptor 3 Market
The global Metabotropic Glutamate Receptor 3 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Metabotropic Glutamate Receptor 3 Scope and Market Size
Metabotropic Glutamate Receptor 3 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metabotropic Glutamate Receptor 3 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Metabotropic Glutamate Receptor 3 market is segmented into
LY-3020371
VU-0092273
DT-010991
Others

Segment by Application, the Metabotropic Glutamate Receptor 3 market is segmented into
Autism
Chronic Pain
Glioma
Others

Regional and Country-level Analysis
The Metabotropic Glutamate Receptor 3 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Metabotropic Glutamate Receptor 3 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Metabotropic Glutamate Receptor 3 Market Share Analysis
Metabotropic Glutamate Receptor 3 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Metabotropic Glutamate Receptor 3 business, the date to enter into the Metabotropic Glutamate Receptor 3 market, Metabotropic Glutamate Receptor 3 product introduction, recent developments, etc.

The major vendors covered:
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Prexton Therapeutics SA

【レポートの目次】

1 Study Coverage
1.1 Metabotropic Glutamate Receptor 3 Product Introduction
1.2 Market Segments
1.3 Key Metabotropic Glutamate Receptor 3 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Type
1.4.2 LY-3020371
1.4.3 VU-0092273
1.4.4 DT-010991
1.4.5 Others
1.5 Market by Application
1.5.1 Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Application
1.5.2 Autism
1.5.3 Chronic Pain
1.5.4 Glioma
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor 3 Market Size, Estimates and Forecasts
2.1.1 Global Metabotropic Glutamate Receptor 3 Revenue 2015-2026
2.1.2 Global Metabotropic Glutamate Receptor 3 Sales 2015-2026
2.2 Global Metabotropic Glutamate Receptor 3, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Metabotropic Glutamate Receptor 3 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Metabotropic Glutamate Receptor 3 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Metabotropic Glutamate Receptor 3 Competitor Landscape by Players
3.1 Metabotropic Glutamate Receptor 3 Sales by Manufacturers
3.1.1 Metabotropic Glutamate Receptor 3 Sales by Manufacturers (2015-2020)
3.1.2 Metabotropic Glutamate Receptor 3 Sales Market Share by Manufacturers (2015-2020)
3.2 Metabotropic Glutamate Receptor 3 Revenue by Manufacturers
3.2.1 Metabotropic Glutamate Receptor 3 Revenue by Manufacturers (2015-2020)
3.2.2 Metabotropic Glutamate Receptor 3 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Metabotropic Glutamate Receptor 3 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 3 Revenue in 2019
3.2.5 Global Metabotropic Glutamate Receptor 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Metabotropic Glutamate Receptor 3 Price by Manufacturers
3.4 Metabotropic Glutamate Receptor 3 Manufacturing Base Distribution, Product Types
3.4.1 Metabotropic Glutamate Receptor 3 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Metabotropic Glutamate Receptor 3 Product Type
3.4.3 Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 3 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Metabotropic Glutamate Receptor 3 Market Size by Type (2015-2020)
4.1.1 Global Metabotropic Glutamate Receptor 3 Sales by Type (2015-2020)
4.1.2 Global Metabotropic Glutamate Receptor 3 Revenue by Type (2015-2020)
4.1.3 Metabotropic Glutamate Receptor 3 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Metabotropic Glutamate Receptor 3 Market Size Forecast by Type (2021-2026)
4.2.1 Global Metabotropic Glutamate Receptor 3 Sales Forecast by Type (2021-2026)
4.2.2 Global Metabotropic Glutamate Receptor 3 Revenue Forecast by Type (2021-2026)
4.2.3 Metabotropic Glutamate Receptor 3 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Metabotropic Glutamate Receptor 3 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Metabotropic Glutamate Receptor 3 Market Size by Application (2015-2020)
5.1.1 Global Metabotropic Glutamate Receptor 3 Sales by Application (2015-2020)
5.1.2 Global Metabotropic Glutamate Receptor 3 Revenue by Application (2015-2020)
5.1.3 Metabotropic Glutamate Receptor 3 Price by Application (2015-2020)
5.2 Metabotropic Glutamate Receptor 3 Market Size Forecast by Application (2021-2026)
5.2.1 Global Metabotropic Glutamate Receptor 3 Sales Forecast by Application (2021-2026)
5.2.2 Global Metabotropic Glutamate Receptor 3 Revenue Forecast by Application (2021-2026)
5.2.3 Global Metabotropic Glutamate Receptor 3 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Metabotropic Glutamate Receptor 3 by Country
6.1.1 North America Metabotropic Glutamate Receptor 3 Sales by Country
6.1.2 North America Metabotropic Glutamate Receptor 3 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Metabotropic Glutamate Receptor 3 Market Facts & Figures by Type
6.3 North America Metabotropic Glutamate Receptor 3 Market Facts & Figures by Application

7 Europe
7.1 Europe Metabotropic Glutamate Receptor 3 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 3 Sales by Country
7.1.2 Europe Metabotropic Glutamate Receptor 3 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Metabotropic Glutamate Receptor 3 Market Facts & Figures by Type
7.3 Europe Metabotropic Glutamate Receptor 3 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor 3 by Region
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 3 Sales by Region
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 3 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Metabotropic Glutamate Receptor 3 Market Facts & Figures by Type
8.3 Asia Pacific Metabotropic Glutamate Receptor 3 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 3 by Country
9.1.1 Latin America Metabotropic Glutamate Receptor 3 Sales by Country
9.1.2 Latin America Metabotropic Glutamate Receptor 3 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Metabotropic Glutamate Receptor 3 Market Facts & Figures by Type
9.3 Central & South America Metabotropic Glutamate Receptor 3 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor 3 by Country
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor 3 Sales by Country
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor 3 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Metabotropic Glutamate Receptor 3 Market Facts & Figures by Type
10.3 Middle East and Africa Metabotropic Glutamate Receptor 3 Market Facts & Figures by Application

11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Corporation Information
11.2.2 Aevi Genomic Medicine Inc Description and Business Overview
11.2.3 Aevi Genomic Medicine Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Products Offered
11.2.5 Aevi Genomic Medicine Inc Related Developments
11.3 Denovo Biopharma LLC
11.3.1 Denovo Biopharma LLC Corporation Information
11.3.2 Denovo Biopharma LLC Description and Business Overview
11.3.3 Denovo Biopharma LLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Products Offered
11.3.5 Denovo Biopharma LLC Related Developments
11.4 Domain Therapeutics SA
11.4.1 Domain Therapeutics SA Corporation Information
11.4.2 Domain Therapeutics SA Description and Business Overview
11.4.3 Domain Therapeutics SA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Products Offered
11.4.5 Domain Therapeutics SA Related Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Description and Business Overview
11.5.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Products Offered
11.5.5 Eli Lilly and Company Related Developments
11.6 Prexton Therapeutics SA
11.6.1 Prexton Therapeutics SA Corporation Information
11.6.2 Prexton Therapeutics SA Description and Business Overview
11.6.3 Prexton Therapeutics SA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Products Offered
11.6.5 Prexton Therapeutics SA Related Developments
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Metabotropic Glutamate Receptor 3 Market Estimates and Projections by Region
12.1.1 Global Metabotropic Glutamate Receptor 3 Sales Forecast by Regions 2021-2026
12.1.2 Global Metabotropic Glutamate Receptor 3 Revenue Forecast by Regions 2021-2026
12.2 North America Metabotropic Glutamate Receptor 3 Market Size Forecast (2021-2026)
12.2.1 North America: Metabotropic Glutamate Receptor 3 Sales Forecast (2021-2026)
12.2.2 North America: Metabotropic Glutamate Receptor 3 Revenue Forecast (2021-2026)
12.2.3 North America: Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2021-2026)
12.3 Europe Metabotropic Glutamate Receptor 3 Market Size Forecast (2021-2026)
12.3.1 Europe: Metabotropic Glutamate Receptor 3 Sales Forecast (2021-2026)
12.3.2 Europe: Metabotropic Glutamate Receptor 3 Revenue Forecast (2021-2026)
12.3.3 Europe: Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Metabotropic Glutamate Receptor 3 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Metabotropic Glutamate Receptor 3 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Metabotropic Glutamate Receptor 3 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Metabotropic Glutamate Receptor 3 Market Size Forecast by Region (2021-2026)
12.5 Latin America Metabotropic Glutamate Receptor 3 Market Size Forecast (2021-2026)
12.5.1 Latin America: Metabotropic Glutamate Receptor 3 Sales Forecast (2021-2026)
12.5.2 Latin America: Metabotropic Glutamate Receptor 3 Revenue Forecast (2021-2026)
12.5.3 Latin America: Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Metabotropic Glutamate Receptor 3 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Metabotropic Glutamate Receptor 3 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Metabotropic Glutamate Receptor 3 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Metabotropic Glutamate Receptor 3 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Addex Therapeutics Ltd、Aevi Genomic Medicine Inc、Denovo Biopharma LLC、Domain Therapeutics SA、Eli Lilly and Company、Prexton Therapeutics SA

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の代謝型グルタミン酸受容体3市場2026:インサイト・予測(Global Metabotropic Glutamate Receptor 3 Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。